Navigation Links
GeneGo Receives SBIR Grant
Date:1/12/2010

ST. JOSEPH, Mich., Jan. 12 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today they have been awarded a $336K Phase I SBIR grant from the NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES for creating a novel type of predictive signatures for drug resistance. Under this project GeneGo will develop "regulation signatures" which should overcome many shortcomings of existing methods of molecular diagnostics. For this work GeneGo will utilize its extensive, manually-curated database of signaling interactions and recently developed algorithms for identifying key proteins in signaling networks. The work will be performed in collaboration with the Van Andel Institute for Translational Medicine.  

"What we propose here is the novel concept of using inferred activity of key signaling proteins for building predictive models. Our early results indicate that such models should be significantly more robust than currently available diagnostic applications which are based directly on gene or protein levels. We are very excited about the opportunity provided by NIH support to further develop and validate this approach. If successful, the methodology could be replicated for developing predictive models for sensitivity to a broad range of targeted therapies, leading to a number of diagnostic applications such as specialized molecular tests, systems for formulating combination therapies and procedures for selecting patient cohorts for clinical trials," said Andrej Bugrim, GeneGo COO and PI on the grant.

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathw
'/>"/>

SOURCE GeneGo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer
2. WorldHeart Receives Unconditional BTT Study Approval From FDA for Levacor(TM) VAD
3. VIA Pharmaceuticals Receives Delisting Notification From NASDAQ
4. KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010
5. AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Gram-Negative Bloodstream Pathogens
6. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
7. The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R) Wishes Campaign
8. BASFs Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label
9. CareCentrix Receives URAC Health Utilization Management Accreditation
10. Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
11. SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 The western European ... It is largely a replacement market with fewer ... mergers, acquisitions and partnerships are redefining competitive landscape ... research service provides details about revenue forecasts, unit ... trends across the country. The changing landscape makes ...
(Date:9/22/2014)... , September 22, 2014 ... September 25   The second edition of ... are excited to announce the final nominations for the ... announced on the evening of September 25 at The Taj Mahal Palace, ... from applicants based on a variety of qualitative and ...
(Date:9/22/2014)... , Sept. 22, 2014  Elusys Therapeutics, Inc. ... treat infectious disease, today announced it has completed ... of obiltoxaximab (ETI-204). Obiltoxaximab is an anti-toxin in ... data from these studies support the safety and ... at the intended therapeutic dose. The conclusion of ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 2Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6
... Council,joins organizations and individuals across the country and around ... December 1, 2007. Since 1988,World AIDS Day has provided ... to reinvigorate global, national, regional,and local efforts to stop ... AIDS Day is leadership. Nearly 27,years since it was ...
... Results Also Show Potentially Differentiating Pharmacokinetic ... ... Shire plc (LSE: SHP,Nasdaq: SHPGY, TSX: SHQ), the global ... results of a study,showing VYVANSE(TM) (lisdexamfetamine dimesylate), the first ...
Cached Medicine Technology:AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic 2Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 2Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 3Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 4Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 5Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 6
(Date:9/23/2014)... driving force behind many chronic diseases, especially liver ... caused by conditions such as viral hepatitis or ... Now, scientists at Virginia Commonwealth University Massey Cancer ... preclinical studies that blocking the expression of a ... the development and progression of liver cancer by ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 Becker's ... its list of "125 Hospitals and Health Systems ... health systems featured on the list have orthopedic ... earned recognition from several reputable sources. Exceptional orthopedic ... patients, front-line orthopedic research and treat professional athletes. ...
(Date:9/23/2014)... 2014 The "area under the curve of oxygen ... approach to monitoring blood oxygen levels during procedures using ... & Analgesia . , The AUC Desat provides ... lowbut also on the depth, duration, and rate of ... Paul Niklewski, PhD, of University of Cincinnati and colleagues ...
(Date:9/23/2014)... Contrary to what is often assumed about single parents, ... from The Kinsey Institute has found that single parents ... active as often as singles without children -- and ... The study, "Dating and Sexual Behavior Among Single Parents ... online in the Journal of Sex Research ...
(Date:9/23/2014)... September 23, 2014 Kenall Manufacturing, ... expanded its MedMaster™ M4 product line with a ... the M4 product line – currently available with ... – providing more flexibility when designing lighting for ... MedMaster M4 Series include:, •Three sizes available ...
Breaking Medicine News(10 mins):Health News:Study uncovers genetic driver of inflammation, uses it to prevent and treat liver cancer 2Health News:125 Hospitals With Great Orthopedic Programs 2Health News:125 Hospitals With Great Orthopedic Programs 3Health News:125 Hospitals With Great Orthopedic Programs 4Health News:125 Hospitals With Great Orthopedic Programs 5Health News:New measure provides more data on oxygen levels during sedation 2Health News:Kinsey study of single parents' dating, sexual activity contradicts assumptions 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 2Health News:Kenall Expands MedMaster™ M4 Surgical Suite Product Portfolio with New 1'×4' Option 3
... don,t let love interfere with your work, researchers say , ... who found your Valentine at work, here,s good news. , ... negative effect, a new Canadian study finds. , "Most people ... they don,t affect productivity, de-motivate other colleagues or have an ...
... ... Toppers feature 100% Natural Dunlop Latex for an affordable 100% natural latex mattress or ... organic Eco Wool batting, creating an organic latex mattress, free from chemical fire-retardants. ... (PRWEB) February 14, ...
... ... practitioner now seeing patients in the River Walk Medical Arts Building. , ... (PRWEB) February 14, 2010 -- Elias Medical recently ... office is located within the River Walk Medical Arts Building at 9900 Stockdale Highway, adjacent ...
... , LOS ANGELES , ... today by Consumer Watchdog -- Anthem Blue Cross,s announcement today that ... or more should not deter the California Legislature from taking immediate ... Other California health insurers -- including Blue Shield of ...
... Feb. 13 The beauty of budding plants and ... allergy sufferers, though, gardening can be as much a chore as ... cause an onslaught of allergy symptoms, including sneezing, itchy eyes, congestion ... can take a few simple steps to minimize their risk of ...
... Compassion appeared to be contagious in experiment using volunteers ... do a good deed appears to inspire you to do ... , In an experiment, researchers recruited volunteers who watched a ... a clip from "The Oprah Winfrey Show" in which musicians ...
Cached Medicine News:Health News:Office Romance OK With Most Folks 2Health News:Foamsource Introduces Natural Slumber 100% Natural Latex Mattresses & Toppers with Free Shipping 2Health News:Foamsource Introduces Natural Slumber 100% Natural Latex Mattresses & Toppers with Free Shipping 3Health News:Elias Medical Announces Move to New Stockdale Highway Practice 2Health News:Anthem Blue Cross's Announcement That It Will Temporarily Suspend a 39% Health Insurance Rate Increase Should Not Deter Immediate Legislative Action 2Health News:Avoid Allergens to Reap the Rewards of Gardening 2Health News:Avoid Allergens to Reap the Rewards of Gardening 3Health News:Witnessing Uplifting Behavior May Spur Good Deeds 2
Provides a combination of concentrated cold / hot and compression for the wrist...
Provides a combination of concentrated cold / hot and compression for the shoulder...
Provides extended cold therapy to the knee area for acute, chronic, or post-surgical applications. Cryotherapy can reduce pain, swelling and facilitate faster rehabilitation....
... The Philly® One-Piece™ Collar is completely ... padding and features our patented chin support. ... flat, storage is efficiently managed where space ... ensure easy recognition of sizes., ,Either ...
Medicine Products: